JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Linifanib (formerly RG3635, ABT869, AL39324) is an orally bioavailable and ATP-competitive inhibitor of multiple kinases (e.g. VEGFR/PDGFR) with potential antitumor activity. It inhibits KDR, CSF-1R, Flt-1/3 and PDGFRbeta with IC50s of 4 nM, 3 nM, 3 nM/4 nM and 66 nM, respectively. Linifanib exhibits excellent anti-proliferative activity in vitro and high in vivo antitumor efficacy.
References: Mol Cancer Ther. 2006 Apr; 5(4):995-1006; Mol Cancer Ther. 2006 Apr; 5(4):1007-13; Mol Cancer Ther. 2011 Jun; 10(6):949-59.
Chemical Name: N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl) urea
InChi Key: ACPCMBPQKQTAQY-UHFFFAOYSA-N
InChi Code: InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)27(21(24)28)14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)26-25-17/h2-11H, 1H3, (H2, 24, 28)(H3, 23, 25, 26)
SMILES Code: O=C(N)N(C1=CC=C(C2=CC=CC3=C2C(N)=NN3)C=C1)C4=CC(C)=CC=C4F
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!